Hemoptysis in rheumatic heart disease

Area of Science:

• Cardiology
• Pulmonology
• Rheumatology

Background:

• Rheumatic valvular heart disease (RVHD) is a significant global health concern.
• Hemoptysis is a potential symptom in patients with cardiac conditions.
• Understanding the prevalence and characteristics of hemoptysis in RVHD is crucial for patient management.

Purpose of the Study:

• To determine the prevalence of hemoptysis in patients with rheumatic valvular heart disease.
• To describe the characteristics and frequency of hemoptysis in this population.
• To explore potential associations between hemoptysis and clinical factors in RVHD patients.

Main Methods:

• A cross-sectional study was conducted on 107 consecutive patients with RVHD at an Ethiopian cardiology referral clinic.
• Patients were interviewed regarding their history of hemoptysis, including its nature and frequency.
• Clinical data, including physical findings, New York Heart Association classification, and valvular lesions, were reviewed.

Main Results:

• Nearly half (48%) of the patients reported a history of hemoptysis.
• The majority of hemoptysis cases involved blood-streaked sputum rather than frank blood.
• Hemoptysis prevalence did not significantly correlate with sex, physical findings, disease severity (NYHA class), or specific valvular lesions, including mitral stenosis.

Conclusions:

• Hemoptysis is a frequent manifestation in patients with rheumatic valvular heart disease.
• The symptom is generally well-tolerated and does not appear to be strongly associated with disease severity or specific clinical features.
• Further research may explore the underlying mechanisms and optimal management strategies for hemoptysis in RVHD.